New drug trial aims to tackle dual threat of heart failure and diabetes
NCT ID NCT07303556
Summary
This study is testing if a newer diabetes medication called tirzepatide can improve heart function and overall health in people who have both chronic heart failure and type 2 diabetes. 120 adults in Kazakhstan will receive the drug and be closely monitored for 40 weeks. Researchers will also check if a person's genetics affects how well they respond to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PI "National Laboratory Astana", Nazarbayev University
Astana, Kazakhstan, 010000, Kazakhstan
Conditions
Explore the condition pages connected to this study.